Capital Group Private Client Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,017	Closed	-$785K	–	279
2025 Q4	$785K	Sell	1,017 -1,890	-65%	-$1.28M	0.01%	216
2025 Q3	$1.63M	Sell	2,907 -19,965	-87%	-$11.3M	0.03%	185
2025 Q2	$12M	Sell	22,872 -88,130	-79%	-$49.2M	0.1%	133
2025 Q1	$70.4M	Buy	111,002 +19,672	+22%	+$13.5M	0.69%	37
2024 Q4	$65.1M	Sell	91,330 -19,565	-18%	-$16.4M	0.6%	44
2024 Q3	$117M	Buy	110,895 +10,667	+11%	+$11.9M	1.11%	23
2024 Q2	$105M	Sell	100,228 -3,641	-4%	-$3.53M	1.05%	22
2024 Q1	$100M	Buy	103,869 +10,857	+12%	+$10.3M	1.02%	24
2023 Q4	$81.7M	Buy	93,012 +336	+0.4%	+$277K	0.84%	32
2023 Q3	$76.3M	Buy	92,676 +26,108	+39%	+$20.5M	0.93%	31
2023 Q2	$47.8M	Buy	66,568 +41,630	+167%	+$32.1M	0.56%	63
2023 Q1	$20.5M	Buy	24,938 +2,048	+9%	+$1.54M	0.25%	101
2022 Q4	$16.5M	Buy	22,890 +60	+0.3%	+$44.3K	0.21%	114
2022 Q3	$15.7M	Buy	22,830 +82	+0.4%	+$51.6K	0.22%	111
2022 Q2	$13.4M	Sell	22,748 -44	-0.2%	-$28.6K	0.17%	120
2022 Q1	$15.9M	Buy	+22,792	New	+$14.4M	0.17%	120